Evidence map›Paper›PMID 25436036›Full record

ArticleOxidative medicine and cellular longevity2014

CAT, GPX1, MnSOD, GSTM1, GSTT1, and GSTP1 genetic polymorphisms in chronic myeloid leukemia: a case-control study.

Claudia Bănescu, Adrian P Trifa, Septimiu Voidăzan, Valeriu G Moldovan, Ioan Macarie, Erzsebeth Benedek Lazar, Delia Dima, Carmen Duicu, Minodora Dobreanu

Open access · hybridAbstract read
In one paragraph

Article in Oxidative medicine and cellular longevity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed, 5 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 5 syntheses or guidelines pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Association betweenDisease markers · 2018
    Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. An investigation of the relation between catalaseArchives of medical science : AMS · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Claudia BănescuDepartment of Medical Genetics, University of Medicine and Pharmacy Tirgu Mures, 38 Gh. Marinescu Street, 540139 Tirgu Mures, Romania.
Adrian P TrifaDepartment of Medical Genetics, "Iuliu Hatieganu" University of Medicine and Pharmacy, 6 Louis Pasteur Street, 400349 Cluj-Napoca, Romania.
Septimiu VoidăzanDepartment of Epidemiology, University of Medicine and Pharmacy Tirgu Mures, 38 Gh. Marinescu Street, 540139 Tirgu Mures, Romania.
Valeriu G MoldovanDepartment of Medical Genetics, University of Medicine and Pharmacy Tirgu Mures, 38 Gh. Marinescu Street, 540139 Tirgu Mures, Romania.
Ioan MacarieHematology Clinic 1, University of Medicine and Pharmacy Tirgu Mures, 50 Gh. Marinescu Street, 540136 Tirgu Mures, Romania.
Erzsebeth Benedek LazarHematology Clinic 2, University of Medicine and Pharmacy Tirgu Mures, 38 Gh. Marinescu Street, 540139 Tirgu Mures, Romania.
Delia Dima"Ion Chiricuta" Cancer Institute, 34-36 Republicii Street, 400015 Cluj-Napoca, Romania.
Carmen DuicuPediatric Clinic, University of Medicine and Pharmacy Tirgu Mures, 50 Gh. Marinescu Street, 540136 Tirgu Mures, Romania.ORCID 0000-0002-8056-1339
Minodora DobreanuLaboratory Medicine, University of Medicine and Pharmacy Tirgu Mures, 50 Gh. Marinescu Street, 540136 Tirgu Mures, Romania.
Universitatea de Medicină, Farmacie, Științe și Tehnologie „George Emil Palade” din Târgu Mureș · ROInstitute of Oncology Prof. Dr. Ion Chiricuta · ROIuliu Hațieganu University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative damage at the DNA level may be promoted by high levels of reactive oxygen species (ROS), leading to genomic instability and increased neoplastic risk. Superoxide dismutase (SOD), glutathione peroxidase (GPX), and catalase (CAT) enzymes are implicated in the prevention of DNA damage by ROS. The aim of the study was to investigate the relationships between CAT C262T, GPX1 Pro198Leu, MnSOD Ala16Val, GSTM1, GSTT1, and GSTP1 Ile105Val polymorphisms and the risk of CML. No association was observed between CML and variant genotypes of GPX1, MnSOD, GSTM1, and GSTT1 polymorphisms in any of the investigated cases. Our study suggests that the homozygous variant genotype of the GSTP1 Ile105Val gene polymorphisms may be associated with the risk of developing CML (OR = 2.5; 95% CI = 1.08-5.7; P value = 0.02), while the heterozygous genotype of the CAT C262T polymorphism seems to have a protective effect against CML (OR = 0.59, 95% CI = 0.39-0.89, P value = 0.01). In most cases, no association was found between laboratory parameters and prognostic factors and the variant genotype of investigated gene polymorphisms. We concluded that CAT, GPX, MnSOD, GSTM1, and GSTT1 gene polymorphisms are not associated with the risk of CML. Variant genotype of the GSTP1 Ile105Val gene polymorphisms may contribute to the risk of developing CML.

Indexed as

Case-Control StudiesCatalaseFemaleGene FrequencyGenetic Predisposition to DiseaseGenotypeGlutathione PeroxidaseGlutathione Peroxidase GPX1Glutathione S-Transferase piGlutathione TransferaseHumansLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMaleMiddle AgedOxidative StressPolymorphism, GeneticCatalaseGlutathione PeroxidaseGlutathione Peroxidase GPX1Glutathione S-Transferase piglutathione S-transferase T1Glutathione TransferaseGPX1 protein, humanGSTP1 protein, humanSuperoxide Dismutase

Identifiers

PMID25436036
PMCPMC4243135
OpenAlexW2006706821

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.